Imunon, Inc. – NASDAQ:IMNN
Imunon stock price today
Imunon stock price monthly change
Imunon stock price quarterly change
Imunon stock price yearly change
Imunon key metrics
Market Cap | 11.34M |
Enterprise value | N/A |
P/E | -0.22 |
EV/Sales | -34.23 |
EV/EBITDA | 0.60 |
Price/Sales | 20.63 |
Price/Book | 0.18 |
PEG ratio | N/A |
EPS | -2.02 |
Revenue | N/A |
EBITDA | -19.07M |
Income | -18.85M |
Revenue Q/Q | N/A |
Revenue Y/Y | 1780.19% |
Profit margin | -7169.83% |
Oper. margin | -6262.85% |
Gross margin | 0% |
EBIT margin | -6262.85% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeImunon stock price history
Imunon stock forecast
Imunon financial statements
| Jun 2023 | 0 | -5.55M | |
|---|---|---|---|
| Sep 2023 | 0 | -3.47M | |
| Dec 2023 | 7.05M | -4.88M | -69.33% |
| Mar 2024 | 0 | -4.92M |
| 2025 | 10.42M | -25.55M | -245.05% |
|---|---|---|---|
| 2026 | 3.93M | -38.7M | -983.9% |
| 2027 | 17.15M | -4.97M | -29.01% |
| 2028 | 43.95M | -3.25M | -7.41% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 28721694 | 7.20M | 25.09% |
|---|---|---|---|
| Sep 2023 | 24654428 | 6.58M | 26.7% |
| Dec 2023 | 21918069 | 8.53M | 38.92% |
| Mar 2024 | 14324768 | 5.82M | 40.66% |
| Jun 2023 | -6.69M | 3.12M | -6.22M |
|---|---|---|---|
| Sep 2023 | -4.47M | 10.66M | 78.26K |
| Dec 2023 | -3.77M | -3.30M | 30.24K |
| Mar 2024 | -5.87M | 2.38M | 0 |
Imunon alternative data
| Aug 2023 | 31 |
|---|---|
| Sep 2023 | 31 |
| Oct 2023 | 31 |
| Nov 2023 | 31 |
| Dec 2023 | 31 |
| Jan 2024 | 31 |
| Feb 2024 | 31 |
| Mar 2024 | 31 |
| Apr 2024 | 31 |
| May 2024 | 33 |
| Jun 2024 | 33 |
| Jul 2024 | 33 |
Imunon other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2024 | 50000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | LINDBORG STACY director, officer: President an.. | Imunon Common Stock | 25,000 | $0.98 | $24,500 | ||
Purchase | TARDUGNO MICHAEL H director, officer.. | Imunon Common Stock | 25,000 | $1.03 | $25,750 | ||
Purchase | TARDUGNO MICHAEL H director, officer.. | Imunon Common Stock | 25,000 | $1.03 | $25,750 | ||
Purchase | TARDUGNO MICHAEL H director, officer.. | Celsion Corporation Common Stock | 4,000 | $3.53 | $14,128 | ||
Purchase | TARDUGNO MICHAEL H director, officer.. | Celsion Corporation Common Stock | 4,000 | $3.53 | $14,128 | ||
Purchase | FRITZ FREDERICK J. director | Celsion Corporation Common Stock | 5,000 | $4.05 | $20,250 | ||
Purchase | FRITZ FREDERICK J. director | Celsion Corporation Common Stock | 2,000 | $4.69 | $9,372 | ||
Purchase | FRITZ FREDERICK J. director | Celsion Corporation Common Stock | 20,000 | $0.88 | $17,600 | ||
Purchase | BRAUN DONALD P director | Celsion Corporation Common Stock | 5,000 | $1.07 | $5,350 |
| Quarter | Transcript |
|---|---|
| Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 17 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 13 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Imunon stock today?
One share of Imunon stock can currently be purchased for approximately $6.31.
-
When is Imunon's next earnings date?
Unfortunately, Imunon's (IMNN) next earnings date is currently unknown.
-
Does Imunon pay dividends?
No, Imunon does not pay dividends.
-
How much money does Imunon make?
Imunon has a market capitalization of 11.34M.
-
What is Imunon's stock symbol?
Imunon, Inc. is traded on the NASDAQ under the ticker symbol "IMNN".
-
What is Imunon's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Imunon?
Shares of Imunon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Imunon have?
As Jul 2024, Imunon employs 33 workers, which is 6% more then previous quarter.
-
When Imunon went public?
Imunon, Inc. is publicly traded company for more then 26 years since IPO on 1 Mar 1999.
-
What is Imunon's official website?
The official website for Imunon is imunon.com.
-
Where are Imunon's headquarters?
Imunon is headquartered at 997 Lenox Drive, Lawrenceville, NJ.
-
How can i contact Imunon?
Imunon's mailing address is 997 Lenox Drive, Lawrenceville, NJ and company can be reached via phone at +60 9 896 9100.
Imunon company profile:
Imunon, Inc.
imunon.comNASDAQ
33
Biotechnology
Healthcare
Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.
Lawrenceville, NJ 08648
CIK: 0000749647
ISIN: US15117N6022
:
